- Home
- AN vs IONS Comparison
AN vs IONS Comparison
Compare AN & IONS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AN
- IONS
- Stock Information
- Founded
- AN 1991
- IONS 1989
- Country
- AN United States
- IONS United States
- Employees
- AN N/A
- IONS N/A
- Industry
- AN Other Specialty Stores
- IONS Biotechnology: Pharmaceutical Preparations
- Sector
- AN Consumer Discretionary
- IONS Health Care
- Exchange
- AN Nasdaq
- IONS Nasdaq
- Market Cap
- AN 6.6B
- IONS 6.0B
- IPO Year
- AN N/A
- IONS 1991
- Fundamental
- Price
- AN $185.87
- IONS $31.43
- Analyst Decision
- AN Strong Buy
- IONS Buy
- Analyst Count
- AN 9
- IONS 18
- Target Price
- AN $194.78
- IONS $62.00
- AVG Volume (30 Days)
- AN 427.8K
- IONS 1.5M
- Earning Date
- AN 02-11-2025
- IONS 02-19-2025
- Dividend Yield
- AN N/A
- IONS N/A
- EPS Growth
- AN N/A
- IONS N/A
- EPS
- AN 17.39
- IONS N/A
- Revenue
- AN $26,319,600,000.00
- IONS $803,067,000.00
- Revenue This Year
- AN $0.43
- IONS N/A
- Revenue Next Year
- AN $2.09
- IONS $10.85
- P/E Ratio
- AN $10.65
- IONS N/A
- Revenue Growth
- AN N/A
- IONS 30.57
- 52 Week Low
- AN $136.35
- IONS $31.41
- 52 Week High
- AN $197.18
- IONS $52.49
- Technical
- Relative Strength Index (RSI)
- AN 68.83
- IONS 33.19
- Support Level
- AN $181.38
- IONS $32.61
- Resistance Level
- AN $184.81
- IONS $35.37
- Average True Range (ATR)
- AN 3.46
- IONS 1.28
- MACD
- AN 1.47
- IONS -0.30
- Stochastic Oscillator
- AN 96.85
- IONS 0.36
About AN AutoNation Inc.
AutoNation is the second largest automotive dealer in the United States, with 2023 revenue of about $27 billion and over 250 dealerships, plus 53 collision centers. The firm also has 23 AutoNation USA used-vehicle stores, a captive lender, four auction sites, and three parts distributors all across 21 states primarily in Sunbelt metropolitan areas. New-vehicle sales account for nearly half of revenue; the company also sells used vehicles, parts, and repair services as well as auto financing. The company (formerly Republic Industries) spun off its waste management unit (Republic Services) in 1999 and its car rental businesses (ANC Rental) in 2000. Wayne Huizenga founded the company in the 1990s to bring the rollup acquisition strategy to auto retailing, which has proved to be a smart move.
About IONS Ionis Pharmaceuticals Inc.
Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, and rare diseases. Ionis and partner Biogen brought Spinraza to market in 2016 as a treatment for a rare neuromuscular disorder, spinal muscular atrophy, and Biogen launched ALS drug Qalsody in 2023. Ionis brought two additional drugs to market via its cardiovascular-focused subsidiary Akcea, including ATTR amyloidosis drug Tegsedi (2018) and cardiology drug Waylivra (Europe, 2019). Ionis and AstraZeneca launched polyneuropathy drug Wainua in 2024.